DAGLB and Parkinson disease: On the other hand, the elevation of 2-AG levels in the other brain regions as observed in the patients with PD46 likely represents a compensatory response to the loss of DAGLB-mediated 2-AG production in the nigral DANs due to PD-related dopaminergic neurodegeneration.